Experimental treatment for focal hyperglycemic ischemic brain injury in the rat.

Hyperglycemia aggravates ischemic brain injury, possibly due to the activation of signaling pathways involving reactive oxygen species, Src and mitogen-activated protein kinases. The aim of this study was to investigate the effects of the spin trap agent alpha-phenyl-N-tert-butyl nitrone (PBN), the Src family kinase inhibitor PP2 and the MEK1-inhibitor U0126 on focal hyperglycemic ischemic brain injury. Temporary middle cerebral artery occlusion (90 min) was induced in four groups of rats (PBN, PP2, and U0126 vs. control). Neurological testing and tetrazolium red staining were performed after 1 day. PBN decreased the infarct volume by 70% compared with the control (P<0.05) and a tendency towards reduced infarcts was seen in the PP2 or U0126 groups. Furthermore, neurological testing was consistent with the volumetric analysis. In conclusion, PBN appears to be a potential neuroprotective agent in hyperglycemic, focal ischemic brain injury, while the efficacy of PP2 and U0126 could not be confirmed by the present data.
AuthorsNasim Farrokhnia, Magnus W Roos, Andreas Terént, Fredrik Lennmyr
JournalExperimental brain research (Exp Brain Res) Vol. 167 Issue 2 Pg. 310-4 (Nov 2005) ISSN: 0014-4819 [Print] Germany
PMID16261339 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • AG 1879
  • Blood Glucose
  • Butadienes
  • Cyclic N-Oxides
  • Enzyme Inhibitors
  • Neuroprotective Agents
  • Nitriles
  • Nitrogen Oxides
  • Pyrimidines
  • Tetrazolium Salts
  • U 0126
  • Carbon Dioxide
  • phenyl-N-tert-butylnitrone
  • Oxygen
  • Animals
  • Blood Glucose (physiology)
  • Body Temperature (physiology)
  • Brain Ischemia (pathology, prevention & control)
  • Butadienes (therapeutic use)
  • Carbon Dioxide (blood)
  • Cyclic N-Oxides
  • Enzyme Inhibitors (therapeutic use)
  • Hyperglycemia (complications, pathology)
  • Male
  • Neurologic Examination (methods)
  • Neuroprotective Agents (therapeutic use)
  • Nitriles (therapeutic use)
  • Nitrogen Oxides (therapeutic use)
  • Oxygen (blood)
  • Pyrimidines (therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Tetrazolium Salts
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: